Skip to main content
Kent Academic Repository

Recommendations for HER2 testing in the UK

Ellis, Ian O., Dowsett, M., Bartlett, J., Walker, Rosemary A., Cooke, T., Gullick, William J., Gusterson, B., Mallon, E., Lee, P. Barrett (2000) Recommendations for HER2 testing in the UK. Journal of Clinical Pathology, 53 (12). pp. 890-892. ISSN 0021-9746. (doi:10.1136/jcp.53.12.890) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) (KAR id:16065)

The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided.
Official URL:
http://dx.doi.org/10.1136/jcp.53.12.890

Abstract

Determining the HER2 status of breast carcinomas is a prerequisite for the use of the monoclonal antibody trastuzumab (Herceptin(R)), which has recently been licensed for the treatment of metastatic disease. This necessitates a test based on archival material. The preferred analyses are immunohistochemistry with fluorescent in situ hybridisation (FISH) as a follow up test for ambiguous results. Guidelines have been developed for standardised, well controlled procedures for the provision of reliable results. A group of three reference laboratories has been established to provide advice, quality assurance, and materials, where needed.

Item Type: Article
DOI/Identification number: 10.1136/jcp.53.12.890
Uncontrolled keywords: HER2 • breast cancer • Herceptin
Subjects: R Medicine > RB Pathology
R Medicine > RC Internal medicine > RC254 Neoplasms. Tumors. Oncology
Divisions: Divisions > Division of Natural Sciences > Biosciences
Depositing User: O.O. Odanye
Date Deposited: 19 May 2009 00:59 UTC
Last Modified: 16 Nov 2021 09:54 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/16065 (The current URI for this page, for reference purposes)

University of Kent Author Information

Gullick, William J..

Creator's ORCID:
CReDIT Contributor Roles:
  • Depositors only (login required):

Total unique views for this document in KAR since July 2020. For more details click on the image.